The economic crisis and cancer chemotherapy: The role of the oncologist

Tumori

Volumn 98, Issue 4, 2012, Pages 532-533

  Rescigno, Paola ^a   Imbevaro, Silvia ^a   Jirillo, Antonio ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AWARENESS; CANCER CHEMOTHERAPY; CLINICAL PRACTICE; COST CONTROL; ECONOMIC RECESSION; FINANCIAL MANAGEMENT; HEALTH CARE COST; LETTER; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; ONCOLOGIST; PATIENT CARE; PATIENT SELECTION; PHYSICIAN ATTITUDE; PROFESSIONAL STANDARD; RESOURCE ALLOCATION;

EID: 84867210620     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161209800420     Document Type: Letter

References (9)

1. Smith TJ, Hillner BE: Bending the cost curve in cancer care. N Engl J Med, 364: 2060-2065, 2011.
2. Stark CJ: The economic burden of cancer in Europe. EJHP Practice, 12: 53-56, 2006.
3. Bernardi A, Jirillo A, Pegoraro R, Bonavina G: Allocation of public sources in oncology: which role can ethics play? Ann Oncol, 18: 1129-1131, 2007. (Pubitemid 47244356)
4. de Belvis AG, Ferrè F, Specchia ML, Valerio L, Fattore G, Ricciardi W: The financial crisis in Italy: implications for the healthcare sector. Health Policy, 106: 10-16, 2012.
5. Garattini S, Bertelè V: Ethics in clinical research. J Hepatol, 51: 792-797, 2009.
6. Apolone G, Tafuri G, Trotta F, Garattini S: A new anti-cancer drug in the market: Good news for investors or for patients? Eur J Cancer, 44: 1786-1788, 2008.
7. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ: Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med, 363: 711-723, 2010.
8. Jirillo A, Imbevaro S, Mazurek M: The impact of new cancer drugs in real practice oncology: a monoinstitutional experience. Immunopharmacol Immunotoxicol, Jan 13, 2012 [Epub ahead of print].
9. Sobrero A, Bruzzi P: Incremental advance or seismic shift? The need to raise the bar of efficacy for drug approval. J Clin Oncol, 27: 5868-5873, 2009.